Cancer Protein Description

This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.


Protein Name: APEX1
Gene Name: APEX1
Protein Full Name: DNA-(apurinic or apyrimidinic site) lyase
Alias: AP endonuclease 1; APE; APE1; APE-1; APEN; APEX; APEX nuclease; APEX nuclease (multifunctional DNA repair enzyme) 1; APX; EC 4.2.99.18; HAP1; REF1; REF-1; REF-1 protein
Mass (Da): 35423
Number AA: 318
UniProt ID: P27695
Locus ID: 328
COSMIC ID: APEX1
Gene location on chromosome: 14q11.2
Cancer protein type: TSP
Effect of cancer mutation on protein: LOSS
Effect of active protein on cancer: INHIBIT
Number of cancer specimens: 20150
Percent of cancer specimens with mutations: 0.16
Mutations observed as inherited: Certain polymorphisms lead to decreased DNA activity
Found in amplified chromosomal regions in human cancers: NA
Deregulated in translocations: NA
Deregulated by viral insertion: NA
Transduced into viral genome: NA
Gene undergoes hypermethylation: NA
Normal role description: APEX1 is an apurinic/apyrimidinic endodeoxyribonuclease in the DNA base excision repair system. It assists in the repair of oxidative and alkylative damage by generating a single strand break surrounding the site of damage. It may also have a role in DNA demethylation and epigenetic regulation of gene expression. APEX1 can exert reversible redox activity on transcriptional activators such as FOS/JUN AP-1 complex to regulate DNA binding affinity. It can also downregulate expression by directly binding to DNA and inhibiting access by transcriptional activators, as in calcium-dependent downregulation of parathyroid hormone, or also enhance promoter activities as in YBX-1-mediated MDR1 promoter activity.


Provide the gene name, protein name, UniProt ID or Locus ID as a search term. Click on Retrieve Info button to obtain information on the selected cancer protein.